Category: Pricing
Global Pricing
-
Al in Biotechnology Market by Function (Drug Design & Optimisation, Biomarker, SAR; Clinical Trial Design, Data Assessment, RWE, Inventory, Supply chain, Logistics; Launch, Pricing, Patient Engagement, Adverse Events), & End User - Global Forecast to 2029
... 2029 The global AI in biotechnology market is projected to reach USD 7.75 billion by 2029 from USD 3.23 billion in 2024, at a high CAGR of 19.1% during the forecast period. The market is ... Read More
-
Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024–2029
... follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market strategies. To cater to the ever-evolving market landscapes across ... Read More
-
The 2025-2030 World Outlook for Vaccines Sales
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
Cloud Computing in Healthcare Market by Product (Healthcare Payer Solutions, Healthcare Provider Solutions), Component (Services, Software), Pricing Model, SERVICE MODEL, Deployment Model - Global Forecast 2024-2030
... at USD 49.40 billion in 2023 and expected to reach USD 58.93 billion in 2024, at a CAGR 19.39% to reach USD 170.82 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027 (Global Almanac)
... also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare ... Read More
-
Impact of Inflation on the Healthcare Sector by Physicians Perspective, Patient Treatment, Regional Analysis, Drug Prices and Treatment Costs - Thematic Intelligence
... continues to examine the impact of inflation on healthcare systems, patients, and HCPs. The report provides an overview of the current and future outlook of the healthcare sector, government policies, innovative technologies, and initiatives that ... Read More
-
Vaccine Market Report 2022
... more than double to $83.5 billion by 2027. The U.S. alone is projected to reach $30 billion by 2027. Routine Vaccinations Continued To Lag In 2021. Pandemic-driven declines in routine vaccines persisted in 2021. Compared ... Read More
-
The 2023-2028 World Outlook for Vaccines Sales
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
IDC Perspective: Real-World Evidence and Drug Pricing in 2022
... patients, private and government healthcare payers, life science companies, and society at large. "As life science companies, private and public healthcare payers, and healthcare providers learn to use RWE to discover the true value of ... Read More
-
NASH Drug Pipeline and Market Overview
... of the liver (cirrhosis). No medications have been approved specifically for NASH but there are numerous products in development. NASH Drug Pipeline and Market Overview looks at the almost 80 drug candidates for the treatment ... Read More
Research Assistance
